Explore Our Library of Biomanufacturing Resources & Technical Data

Application Notes

Cellastim S – Reconstitution Application Note

Enhanced Cryopreservation of T Cells Using Optibumin®, Recombinant Human Serum Albumin (rHSA)

Exbumin – Stabilizing Virus with Albumin to Improve Yield Application Note

High-Resolution Analytical Characterization of Optibumin®: Structural Homogeneity and Functional Consistency Compared to Plasma-Derived HSA

ITS-Animal-Free™ Supplementation for iPSC Expansion and Pluripotency: A Platform Approach for Serum-Free Cell Expansion

Lentivirus Production Protocol in Serum-Free Conditions – How To Improve Transfection Efficiency and Titer Yield

OptiVERO – Expansion of VERO Cells Without Serum in Chemically Defined Cell Culture Media

Preserving Lentiviral Titer During Sterile Filtration Using Recombinant Albumin

Recombinant Albumin as a Carrier Protein Improves Cytokine Recovery and Functional Stability at Dilute Concentrations

Recombinant Albumin Improves Lentiviral Vector Recovery After Freeze-Thaw Stress

Recombinant Albumin Reduces Lentiviral Vector Titer Loss During 24-Hour Hold Times

rHSA Improves Infectious Lentiviral Titer Yield During Tangential Flow Filtration by Passivating Filter Surfaces

Safe, Consistent Iron Delivery in Serum-Free Systems with Optiferrin® Recombinant Transferrin

Sustained T Cell Proliferation and Early Memory Retention with OptiLeukin™ 2 Recombinant IL-2

T Cell Cryopreservation Using Exbumin®, Recombinant Human Serum Albumin, and Reduced DMSO

Thiol by Combat: Enhanced Covalent Conjugation with Recombinant Albumin Compared to Human Plasma-Derived Albumin

Blog

Cryopreservation Just Got Better with Optibumin® 25

Evolving Challenges in Closed-System Biomanufacturing

Explore the Latest Developments in T-reg Research and Clinical Application

High-Performance Production of Viral Vectors for Cell and Gene Therapy Using OptiPEAK HEK293t Complete Media

How Regulatory Bodies Are Driving the Shift to Animal-Origin-Free Solutions in Cell Therapy and Vaccine Development

Innovative Solutions in Closed-System Biomanufacturing: Exploring the Tools and Technologies Driving Sterility and Efficiency

Safety and Contamination Risks: The Testing Burden and Persistent Threats

Scaling Innovation: How DiscGenics and InVitria are Leading the Future of Cell Therapy

Variability and Failed Lots: The Hidden Quality Control Challenge of Serum & Serum-Derived Products

Why Do Some Biologics Cross the Finish Line—While Others Crash and Burn?

Catalog

InVitria Product Catalog

Data Sheets

Cellastim S – Data Sheet

Exbumin – Data Sheet

ITS Animal-Free – Data Sheet

ITSE Animal-Free – Data Sheet

ITSE+A Animal-Free – Data Sheet

Lacromin – Data Sheet

LIF Leukemia Inhibitory Factor – Data Sheet

Lysobac – Data Sheet

Optibumin 20 – Data Sheet

Optibumin 25 – Data Sheet

Optiferrin – Data Sheet

OptiVERO – Data Sheet

News

Evonik Interview: How Recombinant Albumin De-Risks Cell Therapy Manufacturing

InVitria Joins NSF Engineering Research Center for Cell Manufacturing Technologies (CMaT)

InVitria Presents ASGCT 2026 Data on rHSA for Lentiviral Vector Manufacturing

Posters

Adherent HEK293t Cells Cultured in Pall’s iCELLis® Bioreactor with OptiPEAK HEK293t Blood-Free Chemically Defined Media Exhibit Robust and Rapid Population Doubling Times

Recombinant Albumin Enhances Lentiviral Vector Stability During Downstream Processing

Virus Yield Improvement for Downstream Processing: Exbumin®, Excipient Recombinant Albumin

Product Brochures

ITSE AF – Brochure

Optiferrin – Product Brochure

Product Specifications

ITS – Specifications

SDS

Exbumin – Safety Data Sheet

ITS AF – Safety Data Sheet

ITSE AF – Safety Data Sheet

ITSE+A – Safety Data Sheet

Lacromin – Safety Data Sheet

Lysobac – Safety Data Sheet

Optibumin 20 – Safety Data Sheet

Optibumin 25 – Safety Data Sheet

Optiferrin – Safety Data Sheet

Cellastim S – Safety Data Sheet

Use Guidelines

Cellastim S – Guidelines for Use

Exbumin – Guidelines for Use

ITS – Guidelines for Use

ITSE AF – Guidelines for Use

ITSE+A – Guidelines for Use

Optibumin 20 – Guidelines for Use

Optiferrin – Guidelines for Use

Webinar

Accelerating Vaccine Development Through Use of Blood-Free Components

Why Cell Quality Erodes During Downstream Processing — and How to Prevent It | Webinar

White Papers

Emergence of Blood-Free Recombinant Human Albumin

Process Optimization for Lentivirus Production in the iCELLis® Nano Using a Chemically Defined, Animal Component Free HEK293 Media